According to the research report, the global healthcare reimbursement market size is expected to touch USD 17.63 trillion by 2030, from USD 5.49 trillion in 2022, growing with a significant CAGR of 15.7% from 2022 to 2030.
The healthcare reimbursement report offers
a comprehensive study of the current state expected at the major drivers,
market strategies, and key vendors’ growth. The report presents energetic
visions to conclude and study the market size, market hopes, and competitive
surroundings. The research also focuses on the important achievements of the
market, research & development, and regional growth of the leading
competitors operating in the market. The current trends of the global healthcare
reimbursement in conjunction with the geographical landscape of this vertical
have also been included in this report.
The report offers intricate dynamics about
different aspects of the global healthcare reimbursement market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global healthcare reimbursement during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1586
| Report Coverage | Details |
| Market Size by 2030 | USD 17.63 trillion |
| Growth Rate from 2022 to 2030 | CAGR of 15.7% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Claim, Payers, Service Provider, Geography |
This study covers a detailed segmentation
of the global healthcare reimbursement market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global healthcare reimbursement market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- UnitedHealth Group
- Aviva
- Allianz
- CVS Overall health
- BNP Paribas
- Aetna
- Nippon Life Insurance policies
- WellCare Health Ideas
- Agile Health Insurance
- Violet Cross Blue Cover Association.
Market Segmentation
- Fully Paid
- Underpaid
By Payers
- Private
- Public
By Service Provider
- Hospitals
- Diagnostic Labs
- Physician Office
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global healthcare reimbursement report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global healthcare reimbursement market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Healthcare Reimbursement Market
5.1. COVID-19 Landscape: Healthcare Reimbursement Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Healthcare Reimbursement Market, By Claim
8.1. Healthcare Reimbursement Market, by Claim Type, 2022-2030
8.1.1. Fully Paid
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Underpaid
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Healthcare Reimbursement Market, By Payers
9.1. Healthcare Reimbursement Market, by Payers, 2022-2030
9.1.1. Private
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Public
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Healthcare Reimbursement Market, By Service Provider
10.1. Healthcare Reimbursement Market, by Service Provider, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostic Labs
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Physician Office
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Healthcare Reimbursement Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Claim (2017-2030)
11.1.2. Market Revenue and Forecast, by Payers (2017-2030)
11.1.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Claim (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Payers (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Claim (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Payers (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Claim (2017-2030)
11.2.2. Market Revenue and Forecast, by Payers (2017-2030)
11.2.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Claim (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Payers (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Claim (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Payers (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Claim (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Payers (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Claim (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Payers (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Claim (2017-2030)
11.3.2. Market Revenue and Forecast, by Payers (2017-2030)
11.3.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Claim (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Payers (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Claim (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Payers (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Claim (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Payers (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Claim (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Payers (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Claim (2017-2030)
11.4.2. Market Revenue and Forecast, by Payers (2017-2030)
11.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Claim (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Payers (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Claim (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Payers (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Claim (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Payers (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Claim (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Payers (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Claim (2017-2030)
11.5.2. Market Revenue and Forecast, by Payers (2017-2030)
11.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Claim (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Payers (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Claim (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Payers (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
Chapter 12. Company Profiles
12.1. UnitedHealth Group
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Aviva
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Allianz
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. CVS Overall health
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. BNP Paribas
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Aetna
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Nippon Life Insurance policies
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. WellCare Health Ideas
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Agile Health Insurance
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Violet Cross Blue Cover Association.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments